• Thumbnail for R13 (drug)
    displayed a good drug profile in animal studies, it showed almost no conversion into tropoflavin in human liver microsomes. In contrast to R7, R13 is readily...
    5 KB (261 words) - 13:14, 3 December 2023
  • Malaysia R-13 regional road (Montenegro) R13 (drug), an antidementia agent R-13 (missile), a Soviet missile system R13 (Rodalies de Catalunya), a regional...
    836 bytes (142 words) - 21:58, 3 November 2022
  • Amivantamab (category Drugs with non-standard legal status)
    May 2021, and in the European Union in December 2021. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication. Amivantamab...
    23 KB (1,801 words) - 21:23, 31 August 2024
  • Thumbnail for José Rodrigo Aréchiga Gamboa
    José Rodrigo Aréchiga Gamboa (category Mexican drug traffickers)
    possible murders of the drug lord: Noé Castro (alias "R1"), Aréchiga Gamboa's right-hand man in Los Cabos; and a man known by his alias "R13". His most common...
    45 KB (4,212 words) - 22:19, 28 August 2024
  • Thumbnail for Amitriptyline
    Amitriptyline (category Drugs with non-standard legal status)
    in the late 1950s by scientists at Merck and approved by the US Food and Drug Administration (FDA) in 1961. It is on the World Health Organization's List...
    92 KB (8,671 words) - 18:15, 17 August 2024
  • Thumbnail for R7 (drug)
    the preclinical stage of development. R7 was superseded by R13 because while R7 had a good drug profile in animals, it showed almost no conversion into tropoflavin...
    9 KB (692 words) - 17:17, 8 June 2024
  • Thumbnail for Graves' disease
    pathophysiology of Graves' disease". European Journal of Endocrinology. 168 (1): R13-8. doi:10.1530/EJE-12-0539. PMID 23027804. Tomer Y, Davies TF (February 1993)...
    63 KB (6,485 words) - 12:22, 30 August 2024
  • Thumbnail for Digoxin
    Digoxin (category Peripherally selective drugs)
    tumor characteristics and relapse risk". Breast Cancer Research. 15 (1): R13. doi:10.1186/bcr3386. PMC 3672748. PMID 23421975. Ahern TP, Tamimi RM, Rosner...
    47 KB (4,845 words) - 07:24, 4 May 2024
  • Thumbnail for Tyrosine kinase inhibitor
    A tyrosine kinase inhibitor (TKI) is a pharmaceutical drug that inhibits tyrosine kinases. Tyrosine kinases are enzymes responsible for the activation...
    10 KB (1,179 words) - 18:31, 8 August 2024
  • Thumbnail for Cabozantinib
    Cabozantinib (category Multiple chemicals in Infobox drug)
    cabozantinib in its capsule formulation was approved by the US Food and Drug Administration (FDA) under the name Cometriq for treating people with medullary...
    21 KB (1,649 words) - 23:02, 17 April 2024
  • Thumbnail for Selpercatinib
    Selpercatinib (category Drugs with non-standard legal status)
    aged twelve years of age and older in 2020. In June 2024, the US Food and Drug Administration granted traditional approval to selpercatinib for people aged...
    25 KB (2,090 words) - 02:22, 16 July 2024
  • Thumbnail for Taraji P. Henson
    Race for What Pitt Calls -- Our Highest Honour", Globe & Mail, Toronto, p. R13 Viera, Lauren (December 21, 2008). "The curious case of Taraji P. Henson"...
    54 KB (4,085 words) - 18:00, 20 August 2024
  • Thumbnail for Dihexa
    Dihexa (category Chemical pages without DrugBank identifier)
    known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is an oligopeptide drug derived from angiotensin IV that binds with high affinity to hepatocyte growth...
    6 KB (460 words) - 19:16, 8 July 2024
  • Growth factor (redirect from Trophic drug)
    DMAQ-B1 HIOC LM22A-4 N-Acetylserotonin NT-3 NT-4 Norwogonin (5,7,8-THF) R7 R13 TDP6 Antagonists: ANA-12 Cyclotraxin B Gossypetin (3,5,7,8,3',4'-HHF) Ligands:...
    10 KB (1,131 words) - 19:14, 31 March 2024
  • Thumbnail for 5-HT receptor
    5-HT1A and 5-HT1B receptors". European Journal of Pharmacology. 321 (3): R11–R13. doi:10.1016/S0014-2999(97)00050-2. PMID 9085055. Prow MR, Martin KF, Heal...
    65 KB (5,263 words) - 10:40, 12 August 2024
  • R10 titin-related LGMD R11 POMT1-related LGMD R12 anoctamin5-related LGMD R13 Fukutin-related LGMD R14 POMT2-related LGMD R15 POMGnT1-related LGMD R16...
    9 KB (899 words) - 01:15, 30 January 2023
  • Francisco Rafael Arellano Félix (category Mexican drug traffickers)
    October 1949 – 18 October 2013) was a Mexican drug lord and former leader of the Tijuana Cartel, a drug trafficking organization. He was the oldest of...
    55 KB (5,756 words) - 23:38, 31 August 2024
  • [clarification needed] Bergers and Hanahan concluded in 2008 that anti-VEGF drugs can show therapeutic efficacy in mouse models of cancer and in an increasing...
    14 KB (1,671 words) - 06:48, 24 August 2024
  • Thumbnail for Lenvatinib
    Lenvatinib (category Multiple chemicals in Infobox drug)
    treatment with radioactive iodine (radioiodine). In May 2016, the US Food and Drug Administration (FDA) approved it (in combination with everolimus) for the...
    11 KB (934 words) - 23:22, 24 August 2024
  • Thumbnail for ALTO-100
    ALTO-100 (category Drugs not assigned an ATC code)
    ALTO-100, previously known as NSI-189 (NeuralStem Inc. 189), is a drug described as a hippocampal neurogenesis stimulant and indirect brain-derived neurotrophic...
    39 KB (3,842 words) - 15:33, 2 September 2024
  • Thumbnail for Asciminib
    Asciminib (category Multiple chemicals in Infobox drug)
    Investigational Drugs. 30 (8): 803–811. doi:10.1080/13543784.2021.1941863. PMID 34130563. S2CID 235450899. "Drug Trials Snapshots: Scemblix". U.S. Food and Drug Administration...
    17 KB (1,263 words) - 09:31, 30 July 2024
  • Thumbnail for Trametinib
    Trametinib (category Drugs with non-standard legal status)
    medication used for the treatment of melanoma and glioma. It is a MEK inhibitor drug with anti-cancer activity. It inhibits MEK1 and MEK2. It is taken by mouth...
    15 KB (975 words) - 03:53, 27 June 2024
  • Thumbnail for Sunitinib
    Sunitinib (category Multiple chemicals in Infobox drug)
    gastrointestinal stromal tumor (GIST) in January 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications. As of August 2021...
    36 KB (3,447 words) - 05:37, 9 August 2024
  • Reclusa P, et al. (May 2017). "FGFR a promising druggable target in cancer: Molecular biology and new drugs" (PDF). Critical Reviews in Oncology/Hematology...
    8 KB (827 words) - 22:08, 3 December 2023
  • Thumbnail for Trastuzumab deruxtecan
    Trastuzumab deruxtecan (category Antibody-drug conjugates)
    Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin)...
    25 KB (2,086 words) - 02:24, 16 July 2024
  • Thumbnail for Wheelchair curling
    "Rules and Regulations". World Curling Federation. Retrieved 19 March 2018. R13. WHEELCHAIR CURLING ... (h) For WCF wheelchair competitions, each on-ice...
    6 KB (695 words) - 10:49, 3 September 2024
  • Program, not renewable and limited to 2 years, with a maximum of $50k/year. R13, NIH Support for Conferences and Scientific Meetings R15, NIH Academic Research...
    10 KB (1,247 words) - 01:45, 14 August 2024
  • Thumbnail for Dexamethasone
    Dexamethasone (category COVID-19 drug development)
    Dexamethasone intravitreal steroid implants have been approved by the US Food and Drug Administration (FDA) to treat ocular conditions such as diabetic macular...
    68 KB (5,999 words) - 20:41, 31 August 2024
  • Bevacizumab (category Drugs with non-standard legal status)
    endorsement from the drug. The June 2011 meeting of the FDA's oncologic drug advisory committee was the last step in an appeal by the drug's maker. The committee...
    73 KB (6,440 words) - 02:59, 3 September 2024
  • Thumbnail for Nintedanib
    Nintedanib (category Multiple chemicals in Infobox drug)
    received U.S. Food and Drug Administration (FDA) approval for use for idiopathic pulmonary fibrosis in 2014 – one of only two drugs available for treating...
    34 KB (3,021 words) - 12:39, 5 August 2024